Gut Microbiota and Pulmonary Complications After Non Cardiac Elective Surgery in Elderly Patients

February 26, 2025 updated by: Huang YuGuang, Peking Union Medical College Hospital

This study adopts a combination of retrospective and prospective cohort research methods to explore the composition of preoperative oropharyngeal and gut microbiota in elderly patients undergoing elective upper abdominal surgery, aiming to analyze the correlation between preoperative oropharyngeal and intestinal microbiota composition and metabolite levels and the occurrence of postoperative pulmonary complications (PPCs). The research subjects of the retrospective cohort study were participants (ClinicalTrials.gov No. NCT05679661) included in the prospective RCT on the effects of perioperative immune nutrition intervention and oral hygiene on postoperative complications in elderly patients, which was conducted at Peking Union Medical College Hospital from January 2023 to present. The prospective cohort study plans to continue enrolling elderly patients aged ≥ 65 who underwent elective upper abdominal surgery.

This study collects preoperative oropharyngeal and fecal samples, as well as preoperative plasma from patients for microbial sequencing and untargeted metabolomics analysis. The main outcome measurement is PPCs, which include pneumonia, atelectasis, and hypoxemia within 7 days after surgery. Inflammatory cells and cytokines in peripheral blood are secondary outcomes.

Study Overview

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100730
        • Recruiting
        • Department of Anesthesiology, Peking Union Medical College Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Elderly patients over 65 years old who plan to undergo elective upper abdominal surgery

Description

Inclusion Criteria:

  1. Age: ≥ 65 years old;
  2. Surgery: Upper abdominal surgery (expected duration ≥ 2 hours);
  3. Anesthesia methods: general anesthesia, tracheal intubation;
  4. ASA classification: I-IV levels;
  5. Postoperative Pulmonary Complications Risk Score (ARISCAT): Medium to High Risk
  6. Patients or their families are able to understand the research protocol and are willing to participate in this study, providing written informed consent

Exclusion Criteria:

  1. Emergency surgery;
  2. This is the second surgery within the past month;
  3. Preoperative presence of pulmonary infection or other serious pulmonary complications
  4. Patients who have used antibiotics, probiotics, and acid suppressants within one month before surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PPCs+ group
Patients who experienced postoperative pulmonary complications belong to the PPC positive group
The included elderly patients are those who are preparing for elective upper abdominal surgery and the surgery time exceeds 2 hours.
PPCs- group
Patients who experienced no postoperative pulmonary complications belong to the PPC negative group
The included elderly patients are those who are preparing for elective upper abdominal surgery and the surgery time exceeds 2 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with postoperative pulmonary complications
Time Frame: Within 7 days after surgery
Including pneumonia, atelectasis, and hypoxemia
Within 7 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of inflammatory cells in peripheral blood before and after surgery
Time Frame: Before and within 7 days after surgery
Inflammatory cells include white blood cells, neutrophil count, and lymphocyte count
Before and within 7 days after surgery
Concentration of inflammatory cytokines in peripheral blood before and after surgery
Time Frame: Before and within 7 days after surgery
Inflammatory factors include high-sensitivity C-reactive protein (CRP) and procalcitonin (PCT)
Before and within 7 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

July 17, 2024

First Submitted That Met QC Criteria

July 17, 2024

First Posted (Actual)

July 22, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 26, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • K5484

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gut Microbiota

Clinical Trials on Elective upper abdominal surgery

Subscribe